Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03004742 · ClinicalTrials.gov registry record · NA
Flavonoid-rich Supplement Influence on the Human Metabolome
A NA study, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT03004742: Completed NA study, sponsored by Appalachian State University.
NCT03004742 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03004742, a NA study, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
This study will measure the effect of ingesting a flavonoid-rich supplement on various biomarkers in overweight/obese women during a 12-week period. The flavonoid-rich supplement contains a mixture of flavonoids including quercetin, catechins from green tea extract, and anthocyanins from bilberry extract, and other food components that facilitate flavonoid bioactivity including fish oil, caffeine, and vitamin C.
Primary Outcome
24-h urine samples collected pre-study and after 12-weeks intervention
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Flavonoid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT03004742 record still lists
NCT03004742 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03004742 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03004742 about?
NCT03004742 is a clinical study titled "Flavonoid-rich Supplement Influence on the Human Metabolome". This study will measure the effect of ingesting a flavonoid-rich supplement on various biomarkers in overweight/obese women during a 12-week period. The flavonoid-rich supplement contains a mixture of flavonoids including quercetin, catechins from green tea extract, and anthocyanins from bilberry ex...
What is the current status of trial NCT03004742?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2015-08. Estimated completion is 2016-12.
What interventions are being tested in trial NCT03004742?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Flavonoid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03004742?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03004742's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia